Long term treatment with omalizumab in adolescent with refractory solar urticaria

BACKGROUND: Solar urticaria represents an uncomfortable form of chronic inducible urticaria. First and second-line treatments are ineffective in some patients, leading to an impairment in their quality of life. Omalizumab represents a safe therapeutic option in case of refractory solar urticaria. CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Iannelli, Mauro, Passanisi, Stefano, Crisafulli, Giuseppe, Arasi, Stefania, Caminiti, Lucia, Zirilli, Giuseppina, Pajno, Giovanni B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480034/
https://www.ncbi.nlm.nih.gov/pubmed/34583772
http://dx.doi.org/10.1186/s13052-021-01151-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480034/
https://www.ncbi.nlm.nih.gov/pubmed/34583772
http://dx.doi.org/10.1186/s13052-021-01151-z

Ejemplares similares